DUBLIN--(BUSINESS WIRE)--The "Myotonic Dystrophy - Pipeline Insight, 2023" drug pipelines has been added to ResearchAndMarkets.com's offering. The "Myotonic Dystrophy - Pipeline Insight, 2023" report ...

LAS VEGAS, Nov. 27, 2024 /PRNewswire/ -- DelveInsight's 'Myotonic Dystrophy Pipeline Insight 2024' report provides comprehensive global coverage of pipeline myotonic dystrophy therapies in various ...

Cellular models used to search for new therapies for myotonic dystrophy type 1 do not usually take into account the diversity of subtypes presented by patients. A study led by researchers from the ...

New research has identified the specific biological mechanism behind the muscle dysfunction found in myotonic dystrophy type 1 (DM1) and further shows that calcium channel blockers can reverse these ...

ALBANY, N.Y. (June 24, 2025) — Two University at Albany researchers working in the RNA Institute at the College of Arts and Sciences have received new funding to support projects focusing on myotonic ...

Thurman M. Wheeler, MD, of the Department of Neurology at Massachusetts General Hospital, is the senior author of a paper published in Nature Communications, "Analysis of human urinary extracellular ...

The myotonic dystrophy market is expected to grow significantly due to the advancements in treatment options, greater healthcare access, and a rising prevalence of the condition, which together foster ...

More than 60 organizations unite to strengthen awareness, registries, research, and access to care for people living with myotonic dystrophy. The progress we’ve made in myotonic dystrophy (DM) over ...

Scientists from The Hospital for Sick Children (SickKids) and University of Las Vegas Nevada (UNLV) have uncovered a genetic link between autism spectrum disorder (ASD) and a rare genetic condition ...

A cardinal sign of myotonic dystrophy type 1 (DM1) is myotonia, slow muscle relaxation after voluntary contraction. Myotonia results from mis-regulated splicing of ...

The MarketWatch News Department was not involved in the creation of this content. An increase in research and development (R&D) activities in myotonic dystrophy is expected to drive market growth by ...